FLC Capital Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $11.1M | Sell |
86,579
-823
| -0.9% | -$96.3K | 1.79% | 12 |
|
|
2026
Q1 | $10.5M | Sell |
87,402
-1,763
| -2% | -$204K | 1.88% | 11 |
|
|
2025
Q4 | $9.39M | Buy |
89,165
+2,558
| +3% | +$240K | 1.73% | 14 |
|
|
2025
Q3 | $7.27M | Buy |
86,607
+2,078
| +2% | +$171K | 1.41% | 19 |
|
|
2025
Q2 | $6.69M | Buy |
84,529
+4,923
| +6% | +$391K | 1.38% | 19 |
|
|
2025
Q1 | $7.15M | Buy |
79,606
+580
| +0.7% | +$54.2K | 1.6% | 16 |
|
|
2024
Q4 | $7.86M | Sell |
79,026
-2,479
| -3% | -$256K | 1.81% | 15 |
|
|
2024
Q3 | $9.26M | Sell |
81,505
-2,990
| -4% | -$355K | 2.14% | 11 |
|
|
2024
Q2 | $10.5M | Sell |
84,495
-108
| -0.1% | -$13.9K | 2.57% | 8 |
|
|
2024
Q1 | $11.2M | Sell |
84,603
-968
| -1% | -$119K | 2.82% | 8 |
|
|
2023
Q4 | $9.33M | Buy |
85,571
+2,697
| +3% | +$280K | 2.51% | 8 |
|
|
2023
Q3 | $8.53M | Sell |
82,874
-483
| -0.6% | -$52.1K | 2.58% | 8 |
|
|
2023
Q2 | $9.62M | Hold |
83,357
| – | – | 2.81% | 8 |
|
|
2023
Q1 | $8.87M | Sell |
83,357
-200
| -0.2% | -$21.6K | 2.71% | 8 |
|
|
2022
Q4 | $9.27M | Sell |
83,557
-89
| -0.1% | -$9.1K | 2.88% | 6 |
|
|
2022
Q3 | $7.2M | Sell |
83,646
-542
| -0.6% | -$48.4K | 2.5% | 10 |
|
|
2022
Q2 | $7.67M | Sell |
84,188
-1,051
| -1% | -$93.2K | 2.56% | 8 |
|
|
2022
Q1 | $6.99M | Buy |
85,239
+10,189
| +14% | +$803K | 1.96% | 13 |
|
|
2021
Q4 | $5.75M | Buy |
75,050
+1,477
| +2% | +$118K | 1.6% | 17 |
|
|
2021
Q3 | $5.53M | Buy |
73,573
+2,040
| +3% | +$155K | 1.63% | 18 |
|
|
2021
Q2 | $5.56M | Sell |
71,533
-2,202
| -3% | -$164K | 1.64% | 19 |
|
|
2021
Q1 | $5.42M | Buy |
73,735
+4,727
| +7% | +$349K | 1.7% | 17 |
|
|
2020
Q4 | $5.39M | Buy |
69,008
+3,491
| +5% | +$267K | 1.79% | 17 |
|
|
2020
Q3 | $4.89M | Buy |
65,517
+2,035
| +3% | +$159K | 1.79% | 15 |
|
|
2020
Q2 | $4.82M | Buy |
63,482
+3,388
| +6% | +$255K | 1.91% | 18 |
|
|
2020
Q1 | $4.41M | Buy |
60,094
+4,358
| +8% | +$343K | 2.05% | 12 |
|
|
2019
Q4 | $4.84M | Sell |
55,736
-969
| -2% | -$79.6K | 1.94% | 13 |
|
|
2019
Q3 | $4.55M | Sell |
56,705
-1,258
| -2% | -$101K | 1.93% | 13 |
|
|
2019
Q2 | $4.65M | Sell |
57,963
-199
| -0.3% | -$15.2K | 1.91% | 14 |
|
|
2019
Q1 | $4.62M | Buy |
58,162
+2,318
| +4% | +$173K | 2.09% | 13 |
|
|
2018
Q4 | $4.07M | Buy |
+55,844
| New | +$3.94M | 2.74% | 12 |
|
Other funds holding MRK
FLC Capital Advisors's MRK Position: Q2 2026 in Review
FLC Capital Advisors reduced its Merck (MRK) stake by 0.94% in Q2 2026, selling an estimated $96.3K and leaving 86,579 shares worth $11.1M. The position accounts for 1.79% of the portfolio, ranked #12.
FLC Capital Advisors first reported a position in MRK in Q4 2018 and has held it in 31 quarters since. The position peaked at $11.2M in Q1 2024. 3,847 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- FLC Capital Advisors held 86,579 shares of Merck worth $11.1M as of Q2 2026.
- FLC Capital Advisors sold 823 Merck shares in Q2 2026, an estimated $96.3K.
- Merck made up 1.79% of FLC Capital Advisors's portfolio in Q2 2026, its #12 holding.
- FLC Capital Advisors first reported a position in Merck in Q4 2018 and has held it in 31 quarters since.
- FLC Capital Advisors's Merck position peaked at $11.2M in Q1 2024.
- 3,847 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on FLC Capital Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.